Vaccination

French-Austrian COVID vaccine in last trial stage

French-Austrian vaccine developer Valneva on Wednesday announced that it had launched a Phase 3 trial of its candidate vaccine against COVID-19—the last testing stage before seeking regulatory approval.

Diseases, Conditions, Syndromes

Sanofi, GSK to start clinical tests of virus vaccine

French pharmaceutical giant Sanofi on Thursday said it would start human trials of the potential coronavirus vaccine it is developing with British peer GSK, following promising preliminary tests.

Health

Chemical cocktails cause health risks for children and adults

A new research study shows that mixtures of chemicals pose health risks to children as well as adults. The concentrations of chemicals found in the European population of adults and children exceeds the safe level by a factor ...

Diseases, Conditions, Syndromes

Europe gives go ahead to market Ebola vaccine

The European Union authorised the marketing of a vaccine against Ebola on Monday, permitting the first wider commercial use of a protection that has helped stem an outbreak in DR Congo.

Vaccination

EU deal on Covid pass paves way for summer travel

The European Parliament and EU member states reached a deal Thursday paving the way for a Covid-19 certificate that will help open up travel in Europe for the key summer season.

Diseases, Conditions, Syndromes

EU's COVID pass worked well, other tools less so: auditors

The EU's COVID pass system worked well to allow continued free movement in the bloc during the coronavirus pandemic, but other tools fared worse, the European Court of Auditors said Wednesday.

Medications

UK alleges GSK paid off competitors to delay drugs

Britain's competition watchdog accused GlaxoSmithKline on Friday of paying off competitors to delay launches of their own versions of GSK's best-selling antidepressant, Seroxat.

Vaccination

WTO inches forward in COVID vaccine patent waiver talks

After months of debate, WTO members on Wednesday took a first, small step towards a deal aimed at boosting production of COVID vaccines and treatments through patent waivers or compulsory licensing deals.

page 17 from 32